Skip to main content
Erschienen in: Rheumatology International 1/2014

01.01.2014 | Original Article

Anti-arthritic effects of FasL gene transferred intra-articularly by an inducible lentiviral vector containing improved tet-on system

verfasst von: Qingyu Shi, Xuebi Tian, Yinlin Zhao, Huiyu Luo, Yuke Tian, Ailin Luo

Erschienen in: Rheumatology International | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to construct and identify an inducible lentiviral vector containing improved tet-on system and FasL gene and observe its effects on pristane-induced arthritis (PIA). FasL gene was amplified from the spleen of Lewis rats by RT-PCR. The tet-on system was improved with insertion of a chicken chromatin insulator (cHS4) element and an rtTA-dependent, tet-responsive element containing modifications of the tetO sequence (TRE-tight1). Pro-apoptosis effect of the vector pTREFasLcHS4V16 on synovial cells was evaluated by flow cytometer in vitro. Anti-arthritis effects of the vector on PIA after intra-articular injection were observed by clinical evaluation and joint histology. Cytokines in synovial tissue were measured by ELISA. The recombinant inducible lentiviral vector pTREFasLcHS4V16 was successfully constructed. The expression response and the pro-apoptosis effects of the vector were doxycycline dose-dependent. The vector injected intra-articularly attenuated the severity of PIA and decreased the level of cytokines in inflamed joints. pTREFasLcHS4V16 with an improved tet-on system can precisely regulate the expression of FasL gene and apoptosis. Anti-arthritis effects were observed after intra-articular injection of the inducible vector.
Literatur
1.
Zurück zum Zitat Liu H, Pope RM (2004) Apoptosis in rheumatoid arthritis: friend or foe. Rheum Dis Clin North Am 30:603–625PubMedCrossRef Liu H, Pope RM (2004) Apoptosis in rheumatoid arthritis: friend or foe. Rheum Dis Clin North Am 30:603–625PubMedCrossRef
2.
Zurück zum Zitat Pope RM (2002) Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2:527–535PubMedCrossRef Pope RM (2002) Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2:527–535PubMedCrossRef
3.
Zurück zum Zitat Peng SL (2006) Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology (Oxford) 45:26–30CrossRef Peng SL (2006) Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology (Oxford) 45:26–30CrossRef
4.
Zurück zum Zitat Asahara H, Hasumuna T, Kobata T, Yagita H, Okumura K, Inoue H, Gay S, Sumida T, Nishioka K (1996) Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. Clin Immunol Immunopathol 81:27–34PubMedCrossRef Asahara H, Hasumuna T, Kobata T, Yagita H, Okumura K, Inoue H, Gay S, Sumida T, Nishioka K (1996) Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. Clin Immunol Immunopathol 81:27–34PubMedCrossRef
5.
Zurück zum Zitat Pundt N, Peters MA, Wunrau C, Strietholt S, Fehrmann C, Neugebauer K, Seyfert C, van Valen F, Pap T, Meinecke I (2009) Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent. Arthritis Res Ther 11:R16PubMedCentralPubMedCrossRef Pundt N, Peters MA, Wunrau C, Strietholt S, Fehrmann C, Neugebauer K, Seyfert C, van Valen F, Pap T, Meinecke I (2009) Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent. Arthritis Res Ther 11:R16PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Zhang H, Gao G, Clayburne G, Schumacher HR (2005) Elimination of rheumatoid synovium in situ using a Fas ligand ‘gene scalpel’. Arthritis Res Ther 7:R1235–R1243PubMedCentralPubMedCrossRef Zhang H, Gao G, Clayburne G, Schumacher HR (2005) Elimination of rheumatoid synovium in situ using a Fas ligand ‘gene scalpel’. Arthritis Res Ther 7:R1235–R1243PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Okamoto K, Asahara H, Kobayashi T, Matsuno H, Hasunuma T, Kobata T, Sumida T, Nishioka K (1998) Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther 5:331–338PubMedCrossRef Okamoto K, Asahara H, Kobayashi T, Matsuno H, Hasunuma T, Kobata T, Sumida T, Nishioka K (1998) Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther 5:331–338PubMedCrossRef
8.
Zurück zum Zitat Adriaansen J, Vervoordeldonk MJ, Tak PP (2006) Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Rheumatology (Oxford) 45:656–668CrossRef Adriaansen J, Vervoordeldonk MJ, Tak PP (2006) Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Rheumatology (Oxford) 45:656–668CrossRef
9.
Zurück zum Zitat Weber W, Fussenegger M (2006) Pharmacologic transgene control systems for gene therapy. J Gene Med 8:535–556PubMedCrossRef Weber W, Fussenegger M (2006) Pharmacologic transgene control systems for gene therapy. J Gene Med 8:535–556PubMedCrossRef
10.
Zurück zum Zitat Osti D, Marras E, Ceriani I, Grassini G, Rubino T, Vigano D, Parolaro D, Perletti G (2006) Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes. J Virol Methods 136:93–101PubMedCrossRef Osti D, Marras E, Ceriani I, Grassini G, Rubino T, Vigano D, Parolaro D, Perletti G (2006) Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes. J Virol Methods 136:93–101PubMedCrossRef
11.
Zurück zum Zitat Apparailly F, Millet V, Noel D, Jacquet C, Sany J, Jorgensen C (2002) Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 13:1179–1188PubMedCrossRef Apparailly F, Millet V, Noel D, Jacquet C, Sany J, Jorgensen C (2002) Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 13:1179–1188PubMedCrossRef
12.
Zurück zum Zitat Joosten LA, Helsen MM, Saxne T, van De Loo FA, Heinegard D, van Den Berg WB (1999) IL-1 Alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 163:5049–5055PubMed Joosten LA, Helsen MM, Saxne T, van De Loo FA, Heinegard D, van Den Berg WB (1999) IL-1 Alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 163:5049–5055PubMed
13.
Zurück zum Zitat Tian X, Wang G, Xu Y, Wang P, Chen S, Yang H, Gao F, Xu A, Cao F, Jin X, Manyande A, Tian Y (2009) An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector. Hum Gene Ther 20:113–123PubMedCrossRef Tian X, Wang G, Xu Y, Wang P, Chen S, Yang H, Gao F, Xu A, Cao F, Jin X, Manyande A, Tian Y (2009) An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector. Hum Gene Ther 20:113–123PubMedCrossRef
14.
Zurück zum Zitat Liu Z, Xu X, Hsu HC, Tousson A, Yang PA, Wu Q, Liu C, Yu S, Zhang HG, Mountz JD (2003) CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 112:1332–1341PubMedCentralPubMedCrossRef Liu Z, Xu X, Hsu HC, Tousson A, Yang PA, Wu Q, Liu C, Yu S, Zhang HG, Mountz JD (2003) CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 112:1332–1341PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Agha-Mohammadi S, O’Malley M, Etemad A, Wang Z, Xiao X, Lotze MT (2004) Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med 6:817–828PubMedCrossRef Agha-Mohammadi S, O’Malley M, Etemad A, Wang Z, Xiao X, Lotze MT (2004) Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med 6:817–828PubMedCrossRef
16.
Zurück zum Zitat Rang A, Will H (2000) The tetracycline-responsive promoter contains functional interferon-inducible response elements. Nucleic Acids Res 28:1120–1125PubMedCentralPubMedCrossRef Rang A, Will H (2000) The tetracycline-responsive promoter contains functional interferon-inducible response elements. Nucleic Acids Res 28:1120–1125PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Villemure JF, Savard N, Belmaaza A (2001) Promoter suppression in cultured mammalian cells can be blocked by the chicken beta-globin chromatin insulator 5′HS4 and matrix/scaffold attachment regions. J Mol Biol 312:963–974PubMedCrossRef Villemure JF, Savard N, Belmaaza A (2001) Promoter suppression in cultured mammalian cells can be blocked by the chicken beta-globin chromatin insulator 5′HS4 and matrix/scaffold attachment regions. J Mol Biol 312:963–974PubMedCrossRef
18.
Zurück zum Zitat Zhao H, Dean A (2005) Organizing the genome: enhancers and insulators. Biochem Cell Biol 83:516–524PubMedCrossRef Zhao H, Dean A (2005) Organizing the genome: enhancers and insulators. Biochem Cell Biol 83:516–524PubMedCrossRef
19.
Zurück zum Zitat Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R (1996) Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 149:1675–1683PubMed Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R (1996) Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 149:1675–1683PubMed
20.
Zurück zum Zitat Holmdahl R, Lorentzen JC, Lu S, Olofsson P, Wester L, Holmberg J, Pettersson U (2001) Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 184:184–202PubMedCrossRef Holmdahl R, Lorentzen JC, Lu S, Olofsson P, Wester L, Holmberg J, Pettersson U (2001) Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 184:184–202PubMedCrossRef
21.
Zurück zum Zitat Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM (1999) Flice-inhibitory protein expression during macrophage differentiation confers resistance to FAS-mediated apoptosis. J Exp Med 190:1679–1688PubMedCentralPubMedCrossRef Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM (1999) Flice-inhibitory protein expression during macrophage differentiation confers resistance to FAS-mediated apoptosis. J Exp Med 190:1679–1688PubMedCentralPubMedCrossRef
Metadaten
Titel
Anti-arthritic effects of FasL gene transferred intra-articularly by an inducible lentiviral vector containing improved tet-on system
verfasst von
Qingyu Shi
Xuebi Tian
Yinlin Zhao
Huiyu Luo
Yuke Tian
Ailin Luo
Publikationsdatum
01.01.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 1/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2002-z

Weitere Artikel der Ausgabe 1/2014

Rheumatology International 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.